Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial.
Health Secur
; 20(S1): S20-S30, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35483093
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
Type of study:
Guideline
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Health Secur
Year:
2022
Document type:
Article
Country of publication: